相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Validation and application of a novel cholesterol efflux assay using immobilized liposomes as a substitute for cultured cells
Yuna Horiuchi et al.
BIOSCIENCE REPORTS (2018)
High-Density Lipoprotein Subspecies Defined by Apolipoprotein C-III and Subclinical Atherosclerosis Measures: MESA (The Multi-Ethnic Study of Atherosclerosis)
Sarah A. Aroner et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2018)
High-Density Lipoprotein Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts
Majken K. Jensen et al.
CIRCULATION (2018)
Apolipoproteins E and CIII interact to regulate HDL metabolism and coronary heart disease risk
Allyson M. Morton et al.
JCI INSIGHT (2018)
ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity
Mengdie Luo et al.
SCIENTIFIC REPORTS (2017)
ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors
Philip L. S. M. Gordts et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
The acidic domain of the endothelial membrane protein GPIHBP1 stabilizes lipoprotein lipase activity by preventing unfolding of its catalytic domain
Simon Mysling et al.
ELIFE (2016)
Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease
Anders Berg Jorgensen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Targeting APOC3 in the Familial Chylomicronemia Syndrome
Daniel Gaudet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Altered Activation of Endothelial Anti- and Proapoptotic Pathways by High-Density Lipoprotein from Patients with Coronary Artery Disease Role of High-Density Lipoprotein-Proteome Remodeling
Meliana Riwanto et al.
CIRCULATION (2013)
Apolipoproteins C-I and C-III Inhibit Lipoprotein Lipase Activity by Displacement of the Enzyme from Lipid Droplets
Mikael Larsson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease
Anastazia A. Kei et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2012)
Comparative proteomic profiling of plasma very-low-density and low-density lipoproteins
Hung-Yu Sun et al.
CLINICA CHIMICA ACTA (2010)
Biochemical characterization of cholesteryl ester transfer protein inhibitors
Mollie Ranalletta et al.
JOURNAL OF LIPID RESEARCH (2010)
Increased plasma apolipoprotein C-III concentration independently predicts cardiovascular mortality: The Hoorn Study
Peter G. Scheffer et al.
CLINICAL CHEMISTRY (2008)
Apolipoprotein C-III: understanding an emerging cardiovascular risk factor
Esther M. M. Ooi et al.
CLINICAL SCIENCE (2008)
Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial
Michael Miller et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Use of Intralipid for kinetic analysis of HDL apoC-III: evidence for a homogeneous kinetic pool of apoC-III in plasma
Minh N. Nguyen et al.
JOURNAL OF LIPID RESEARCH (2006)
Description of the torcetrapib series of cholesteryl ester transfer protein inhibitors, including mechanism of action
RW Clark et al.
JOURNAL OF LIPID RESEARCH (2006)
Apolipoprotein A-V-heparin interactions - Implications for plasma lipoprotein metabolism
A Lookene et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Plasma turnover of HDL apoC-I, apoC-III, and apoE in humans: in vivo evidence for a link between HDL apoC-III and apoA-I metabolism
JS Cohn et al.
JOURNAL OF LIPID RESEARCH (2003)
A case of apolipoprotein C-II deficiency with coronary artery disease
M Kawano et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2002)
Human apolipoprotein C-I accounts for the ability of plasma nigh density lipoproteins to inhibit the cholesteryl ester transfer protein activity
T Gautier et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
